LEADER 01266nam  2200349Ka 450 
001 9910695818103321
005 20070618151647.0
035   $a(CKB)5470000002373613
035   $a(OCoLC)144611782
035   $a(EXLCZ)995470000002373613
100   $a20070618d2007      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aSteroids (anabolic-androgenic)$b[electronic resource] /$fNational Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health & Human Services
210  1$a[Bethesda, Md.] :$cNational Institute on Drug Abuse, National Institutes of Health, U.S. Dept. of Health & Human Services,$d[2007]
215   $a3 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on June 7, 2007).
300   $a"NIDA InfoFacts."
300   $a"March 2007."
517   $aSteroids 
606   $aSteroids$xHealth aspects
615  0$aSteroids$xHealth aspects.
712 02$aNational Institute on Drug Abuse.
712 02$aUnited States.$bDepartment of Health and Human Services.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695818103321
996   $aSteroids (anabolic-androgenic)$93155191
997   $aUNINA